PRELIMINARY PROXY STATEMENT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No.)
Filed by Registrant |
[X] |
|
|
|
|
Filed by Party other than Registrant |
[ ] |
|
|
|
|
Check the appropriate box: |
|
|
[X] |
Preliminary Proxy Statement |
[ ] |
Confidential, for Use of the Commission |
|
|
|
Only (as permitted by Rule 14a-6(e)(2)) |
|
|
|
[ ] |
Definitive Proxy Statement |
[ ] |
Definitive Additional Materials |
|
|
|
[ ] |
Soliciting Materials Pursuant to §240.14a-12 |
|
|
Aspen Group, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other
than the Registrant)
Payment of Filing Fee (Check the appropriate box): |
|
|
[X] |
No fee required. |
|
|
[ ] |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
|
|
|
(1) |
Title of each class of securities to which transaction applies: |
|
(2) |
Aggregate number of securities to which transaction applies: |
|
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): |
|
|
$_____ per share as determined under Rule 0-11 under the Exchange Act. |
|
(4) |
Proposed maximum aggregate value of transaction: |
|
(5) |
Total fee paid: |
|
|
[ ] |
Fee paid previously with preliminary materials. |
[ ] |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
|
(1) |
Amount previously paid: |
|
(2) |
Form, Schedule or Registration Statement No.: |
|
(3) |
Filing Party: |
|
(4) |
Date Filed: |
PRELIMINARY
PROXY STATEMENT
Aspen Group, Inc.
276 Fifth Avenue, Suite 505
New York, New York, 10001
(646) 448-5144
NOTICE OF SPECIAL MEETING OF SHAREHOLDERS
To the shareholders of Aspen Group, Inc.:
We are pleased to invite you to
attend a Special Meeting of the Shareholders (the “Special Meeting”) of Aspen Group, Inc., a Delaware corporation (the “Company”),
which will be held at 9:30 a.m., local time on July 6, 2022 at the Company’s offices located at 4615 E. Elwood Street, Phoenix,
Arizona 85040, for the following purposes:
| 1. | Approve an amendment to the Company’s Certificate of Incorporation to increase the number of shares
of Common Stock the Company is authorized to issue from 40,000,000 shares to 60,000,000 shares (the ‘Authorized Share Increase”);
and |
| 2. | Approve the adjournment of the Special Meeting to a later date or time, if necessary, to permit further
solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes
to approve the Authorized Share Increase. |
The Company’s Board of Directors
(the “Board”) has fixed the close of business on May 12, 2022 as the date for a determination of shareholders entitled to
notice of, and to vote at, the Special Meeting or any adjournment thereof.
Important notice regarding the availability of proxy
materials for the Special Meeting to be held on July 6, 2022: The Notice and Proxy Statement are available at www.proxyvote.com.
This Notice of Special Meeting and the accompanying
proxy statement and form of proxy are first being mailed on or about May 23, 2022 to our shareholders of record entitled to vote at the
Special Meeting.
If You Plan to Attend
Please note that space limitations
make it necessary to limit attendance to shareholders. Registration and seating will begin at 9:30 a.m., local time. Shares can be voted
at the meeting only if the holder is present in person or is represented by valid proxy.
For admission to the meeting, each
shareholder may be asked to present valid picture identification, such as a driver’s license or passport, and proof of stock ownership
as of the Record Date, such as the enclosed proxy card or a brokerage statement reflecting stock ownership. Cameras, recording devices
and other electronic devices will not be permitted at the meeting.
If you do not plan on attending
the meeting, please vote your shares via the internet, by phone or by signing and dating the enclosed proxy and return it in the business
envelope provided. Your vote is very important.
|
By the Order of the Board of Directors |
|
|
|
/s/ Michael Mathews |
|
Michael Mathews |
|
Chief Executive Officer |
Dated: May 23, 2022
Whether or not you expect
to attend in person, we urge you to vote your shares at your earliest convenience. This will ensure the presence of a quorum at the meeting.
Promptly voting your shares via the Internet, by phone or by signing, dating, and returning the enclosed proxy card will save us the expenses
and extra work of additional solicitation. An addressed envelope for which no postage is required if mailed in the United States is enclosed
if you wish to vote by mail. Submitting your proxy now will not prevent you from voting your shares at the meeting if you desire to do
so, as your proxy is revocable at your option. Your vote is important, so please act today!
We have retained Innisfree M&A Incorporated
(“Innis”) to assist in proxy solicitation for the Special Meeting. Should you have any questions or require assistance in
attending the Special Meeting or submitting your proxy, you can contact Innis toll-free at the number set forth below:
Aspen Group, Inc.
(646)
448-5144
Table of Contents
Aspen Group, Inc.
276 Fifth Avenue, Suite 505
New York, New York, 10001
(646) 448-5144
SPECIAL MEETING OF SHAREHOLDERS
PROXY STATEMENT
This Proxy Statement is being sent
to the holders of shares of Common Stock of Aspen Group, Inc., a Delaware corporation (“AGI” or the “Company”)
in connection with the solicitation of proxies by our Board of Directors (the “Board”) for use at a Special Meeting of Shareholders
of the Company which will be held at 9:30 a.m., local time on July 6, 2022 at the Company’s offices located at 4615 E. Elwood Street,
Phoenix, Arizona 85040 (the “Special Meeting”). The Notice of Special Meeting and this Proxy Statement and form of proxy are
first being mailed on or about May 23, 2022 to our shareholders of record entitled to vote at the Special Meeting.
Who is entitled to vote at the Special Meeting?
The Board has fixed the close of
business on May 12, 2022 as the record date (the “Record Date”) for a determination of shareholders entitled to notice of,
and to vote at, the Special Meeting. As of the Record Date, there were 25,202,278 shares of Common Stock, par value $0.001 per share
of the Company outstanding. Each share of the Company’s Common Stock represents one vote that may be voted on each matter that may
come before the Special Meeting. There are no shares of preferred stock, par value $0.001 per share (“Preferred Stock”) outstanding.
What matters will be voted on at the Special Meeting?
The two proposals that are scheduled
to be considered and voted on at the Special Meeting are as follows:
1. Approve
an increase in the number of authorized shares of Common Stock from 40,000,000 shares to 60,000,000 shares (the “Authorized Share
Increase”), and approve a corresponding amendment to the Company’s certificate of incorporation, as amended, to effect the
Authorized Share Increase (together, the “Authorized Share Increase Proposal”); and
2. Approve
the adjournment of the Special Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based
upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve the Authorized Share Increase (the
“Adjournment Proposal”).
What are the Board’s voting recommendations?
The Board of Directors recommends
that you vote “FOR” the Authorized Share Increase Proposal and “FOR” the Adjournment Proposal.
Why does the Company need to hold this vote?
The purpose of the Authorized Share
Increase is to provide for a sufficient reserve of authorized but unissued shares of Common Stock to enable the Company to (i) permit
the issuance of Common Stock underlying and comply with the reserve requirements under outstanding derivative securities convertible into
or exercisable or exchangeable for shares of Common Stock, (ii) allow for future grants which may be made under the Company’s 2018
Equity Compensation Plan, and (iii) give the Board the ability to issue shares of Common Stock or derivative securities, if and when the
Board deems it appropriate to enter into strategic transactions or raise capital. See “Purpose of the Authorized Share Increase”
on page 7 for more information on the purpose and potential effects of the proposed Authorized Share Increase.
What is the difference between holding shares as
a record holder and as a beneficial owner?
If your shares are registered in
your name with the Company’s transfer agent, Action Stock Transfer Corporation, you are the “record holder” of those
shares. If you are a record holder, these proxy materials have been provided directly to you by the Company.
If your shares are held in a stock
brokerage account, a bank or other holder of record, you are considered the “beneficial owner” of those shares held in “street
name.” If your shares are held in street name, these proxy materials have been forwarded to you by that organization. As the beneficial
owner, you have the right to instruct this organization on how to vote your shares.
Who may attend the Special Meeting?
Record holders and beneficial owners
may attend the Special Meeting. If your shares are held in street name, you will need to bring a copy of a brokerage statement or other
documentation reflecting your stock ownership as of the Record Date. Please see below for instructions on how to vote at the Special Meeting
if your shares are held in street name.
How do I vote?
Record Holder
|
1. |
Vote by Internet. The website address for internet voting is on your proxy card. |
|
2. |
Vote by phone. Call 1-800-690-6903 and follow the instructions on your proxy card. |
|
3. |
Vote by mail. Mark, date, sign and mail promptly the enclosed proxy card (a postage-paid envelope is provided for mailing in the United States). |
|
4. |
Vote in person. Attend and vote at the Special Meeting. |
If you vote by Internet or phone,
please DO NOT mail your proxy card.
Beneficial Owner (Holding Shares
in Street Name)
|
1. |
Vote by Internet. The website address for internet voting is on your proxy card. |
|
2. |
Vote by mail. Mark, date, sign and mail promptly the enclosed proxy card (a postage-paid envelope is provided for mailing in the United States). |
|
3. |
Vote in person. Obtain a valid legal proxy from the organization that holds your shares and attend and vote at the Special Meeting. |
What constitutes a quorum?
To carry on the business of the
Special Meeting, we must have a quorum. A quorum is present when a majority of the outstanding shares of stock entitled to vote, as of
the Record Date, are represented in person or by proxy. Shares owned by the Company are not considered outstanding or considered to be
present at the Special Meeting. Broker non-votes and abstentions are counted as present for the purpose of determining the existence of
a quorum.
What happens if the Company is unable to obtain
a quorum?
If a quorum is not present to transact
business at the Special Meeting or if we do not receive sufficient votes in favor of the proposals by the date of the Special Meeting,
the persons named as proxies may propose one or more adjournments of the Special Meeting to permit solicitation of proxies.
How many votes are needed for each proposal to
pass?
Proposals |
|
Vote Required |
|
(1) |
Approve the Authorized Share Increase to increase in the number of authorized shares of Common Stock from 40,000,000 shares to 60,000,000 shares, and approve a corresponding amendment to the Company’s Certificate of Incorporation, as amended, to effect the Authorized Share Increase; |
|
Majority of outstanding shares of Common Stock |
|
(2) |
Approve the adjournment of the Special Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve the Authorized Share Increase. |
|
Majority of the votes cast |
|
What if I am a beneficial owner and I do not give my nominee voting
instructions?
If your shares are held in street
name, you must instruct the organization that holds your shares how to vote. Such organization is bound by the rules of the New York Stock
Exchange, or NYSE, regarding whether or not it can exercise discretionary voting power for any particular proposal in the absence of voting
instructions from you. Brokers have the authority to vote shares for which their customers do not provide voting instructions on certain
“routine” matters. A broker non-vote occurs when a nominee who holds shares for another does not vote on a particular matter
because the nominee does not have discretionary voting authority for that item and has not received instructions from the owner of the
shares or when a broker for its own internal reasons elects not to vote uninstructed shares. Broker non-votes are included in the calculation
of the number of votes deemed present at the meeting for purposes of determining the presence of a quorum.
The table below sets forth, for
each proposal, whether a nominee organization can exercise discretion and vote your shares absent your instructions and if not, the impact
of such broker non-vote on the approval of the proposal.
Proposals |
|
|
Broker Discretionary Vote Allowed |
|
Effect of Broker Non-Votes on the Proposal* |
(1) |
Approve the Authorized Share Increase to increase in the number of authorized shares of Common Stock from 40,000,000 shares to 60,000,000 shares, and approve a corresponding amendment to the Company’s Certificate of Incorporation, as amended, to effect the Authorized Share Increase; |
|
|
Yes |
|
N/A |
(2) |
Approve the adjournment of the Special Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve the Authorized Share Increase. |
|
|
Yes |
|
N/A |
———————
*If you do not provide voting instructions, your shares
will not be voted on any non-routine proposal. Proposals 1 and 2 are considered “routine” proposals, so broker discretionary
voting is permitted under NYSE Rules for each proposal. However, while broker discretionary voting is permitted for these proposals, an
increasing number of brokers and similar organizations which hold shares in street name have elected to either refrain from discretionary
voting or engage in a form of proportionate voting such as voting shares in a manner consistent with all other votes cast at the meeting.
As a result, while broker discretionary voting could result in a vote “FOR” Proposals 1 or 2 for some or all instances in
which a beneficial shareholder declines to provide instructions for voting his, her or its shares, we cannot predict what the ultimate
outcome will be as it depends on the organization which has custody of the shares in each such case.
What is the effect of abstentions?
Proposals |
|
|
Effect of Abstentions on the Proposal |
(1) |
Approve the Authorized Share Increase to increase in the number of authorized shares of Common Stock from 40,000,000 shares to 60,000,000 shares, and approve a corresponding amendment to the Company’s Certificate of Incorporation, as amended, to effect the Authorized Share Increase; |
|
|
Against |
(2) |
Approve the adjournment of the Special Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve the Authorized Share Increase. |
|
|
Against |
What are the voting procedures?
You may vote in favor of each proposal
or against each proposal, or in favor of some proposals and against others, or you may abstain from voting on any of these proposals.
You should specify your respective choices on the accompanying proxy card or your voting instruction form.
Is my proxy revocable?
You may revoke your proxy and reclaim
your right to vote up to and including the day of the Special Meeting by giving written notice to the Corporate Secretary of the Company,
by delivering a proxy card dated after the date of the proxy or by voting in person at the Special Meeting. All written notices of revocation
and other communications with respect to revocations of proxies should be addressed to: Aspen Group, Inc., 276 Fifth Avenue, Suite 505,
New York, New York 10001, Attention: Corporate Secretary.
Who is paying for the expenses
involved in preparing and mailing this proxy statement?
All of the
expenses involved in preparing, assembling and mailing these proxy materials and all costs of soliciting proxies will be paid by the Company.
In addition to the solicitation by mail, proxies may be solicited by the Company’s officers and regular employees by telephone or
in person. Such persons will receive no compensation for their services other than their regular salaries. Arrangements will also be made
with brokerage houses and other custodians, nominees and fiduciaries to forward solicitation materials to the beneficial owners of the
shares held of record by such persons, and we may reimburse such persons for reasonable out of pocket expenses incurred by them in so
doing. We have retained Innisfree M&A Incorporated to assist in proxy solicitation for an estimated fee of $15,000 plus disbursements,
reimbursable expenses and processing and service costs. If you have any questions or require any assistance in voting your shares, please
call Innisfree M&A Incorporated, toll-free, at (877) 800-5195.
Could other matters be decided at the Special Meeting?
Other
than the Authorized Share Increase Proposal and the Adjournment Proposal,
no other matters will be presented for action by the shareholders at the Special Meeting.
What is “householding” and how does
it affect me?
Record holders who have the same
address and last name will receive only one copy of their proxy materials, unless we are notified that one or more of these record holders
wishes to continue receiving individual copies. This procedure will reduce the Company’s printing costs and postage fees. Shareholders
who participate in householding will continue to receive separate proxy cards.
If you are eligible for householding,
but you and other record holders with whom you share an address, receive multiple copies of these proxy materials, or if you hold the
Company’s Common Stock in more than one account, and in either case you wish to receive only a single copy of each of these documents
for your household, please contact the Company’s Corporate Secretary at: Aspen Group, Inc., 276 Fifth Avenue, Suite 505, New York,
New York 10001, Attention: Corporate Secretary.
If you participate in householding
and wish to receive a separate copy of these proxy materials, or if you do not wish to continue to participate in householding and prefer
to receive separate copies of these documents in the future, please contact the Company’s Corporate Secretary as indicated above.
Beneficial owners can request information about householding from their brokers, banks or other holders of record.
Do I have dissenters’ (appraisal) rights?
Appraisal rights are not available
to the Company’s shareholders with any of the proposals brought before the Special Meeting.
Interest of Officers and Directors in Matters to
Be Acted Upon
None of the officers or directors
have any interest in any of the matters to be acted upon at the Special Meeting.
Can a shareholder present a proposal to be considered
at the 2022 Annual Meeting?
For a shareholder proposal to be
considered for inclusion in the Company’s Proxy Statement and proxy card for the next Annual Meeting of Shareholders pursuant to
Rule 14a-8 under the Securities Exchange Act of 1934 (the “Exchange Act”) the following is required:
| · | Our Corporate Secretary must receive the written proposal not later than July 11, 2022, which is 120 calendar
days prior to the one-year anniversary of the date the Company’s proxy materials were released to shareholders in connection with
the 2021 Annual Meeting of the Shareholders (the “2021 Annual Meeting”). Such proposals also must comply with the regulations
of the Securities and Exchange Commission (the “SEC”) under Rule 14a-8 regarding the inclusion of shareholder proposals
in company sponsored materials. |
| · | Our Bylaws include advance notice provisions that require shareholders who desire to recommend or nominate
individuals for election as directors or who wish to present a proposal at the next Annual Meeting to do so in accordance with the terms
of the advance notice provisions. For a shareholder proposal or a director nomination that is not intended to be included in the Company’s
Proxy Statement and proxy card under Rule 14a-8, our Corporate Secretary must receive the written proposal not later than the close of
business on the 120th day (or July 11, 2022) nor earlier than the close of business on the 150th day (or June 11, 2022) prior to the one
year anniversary of the date on which the Company released its proxy materials to its shareholders for the 2021 Annual Meeting; provided,
however, that in the event that the date of the next annual meeting of shareholders is advanced more than 30 days prior to or delayed
by more than 30 days after the anniversary of the 2021 Annual Meeting, for notice by the shareholder to be timely, such shareholder’s
written notice must be delivered to the secretary not later than the close of business on the 90th day prior to the next Annual Meeting
or the 10th day following the day on which public announcement of the date of such meeting is first made, whichever is later. Your
notice must contain the specific information set forth in our Bylaws. |
Additionally, you must be a
record holder at the time you deliver your notice to the Corporate Secretary and be entitled to vote at the next Annual Meeting of Shareholders.
A nomination or other proposal will
be disregarded if it does not comply with the above procedures. All proposals and nominations should be sent to Aspen Group, Inc., 276
Fifth Avenue, Suite 505, New York, New York 10001, Attention: Corporate Secretary.
We reserve the right to amend the
Company’s Bylaws and any change will apply to the next Annual Meeting unless otherwise specified in the amendment.
The Board
Recommends that Shareholders Vote “FOR” Proposals 1 and 2.
PROPOSAL 1. THE AUTHORIZED
SHARE INCREASE PROPOSAL
The Board has approved, and is asking
shareholders to approve an increase in the number of authorized shares of Common Stock 40,000,000 shares to 60,000,000 shares (the “Authorized
Share Increase”) and a corresponding amendment to the Certificate of Incorporation to effect the Authorized Share Increase (the
“Proposed Amendment”).
Approval of the Proposed Amendment
requires the affirmative vote of the holders of a majority of the outstanding shares of Common Stock. At the close of business on the
Record Date, there were 25,202,278 shares of Common Stock outstanding. There are no shares of Preferred Stock outstanding.
Purpose of the Authorized Share Increase
The purpose of the Authorized Share
Increase is to enable the Company to effect potential future issuances under outstanding derivative securities which are convertible into
or exercisable or exchangeable for, shares of the Company’s Common Stock. Under its Certificate of Incorporation, the Company is
currently authorized to issue up to 40,000,000 shares of Common Stock and 1,000,000 shares of Preferred Stock. As of the close of business
on the Record Date, there were 25,202,278 shares of Common Stock issued and outstanding and no shares of Preferred Stock issued and
outstanding. There are also 14,514,529 shares of Common Stock reserved for issuance pursuant to (i) outstanding stock options, restricted
stock units (“RSUs”) and restricted stock under equity incentive plans, (ii) outstanding warrants, (iii) outstanding convertible
notes and (iv) future awards which may be made under the Aspen Group, Inc. 2018 Equity Incentive Plan, leaving a balance of 283,193 shares
of Common Stock available for issuance. This includes shares of Common Stock issuable upon conversion of $10 million of convertible notes
which the Company issued in an offering which closed on March 14, 2022. These notes, which subject to prior conversion or repayment mature
in March 2027, are convertible into shares of the Common Stock at the lender’s option at a conversion price of $1.00 per share any
time after the issuance date. In addition, the notes are mandatorily convertible into shares of Common Stock, should the closing price
of the Common Stock be at least $2.00 per share for 30 consecutive trading days and certain other conditions be met. This mandatory conversion
is subject to each lender’s 9.9% beneficial ownership limitation and is also subject to the Nasdaq combined 19.99% requirement which
generally provides that a listed issuer may not issue 20% or more of its outstanding Common Stock or voting power in a non-public offering
at below a minimum price unless the Company’s shareholders first approve such issuance.
Given the above outstanding securities
and agreements to which the Company is or may become subject, and the nominal amount of shares remaining available for issuance after
giving effect to the foregoing, the Board believes it to be in the best interest of the Company to increase the number of shares of Common
Stock the Company is authorized to issue in order to enable the Company to comply with its contractual obligations while also giving the
Company greater flexibility in addressing its future general corporate needs, including, but not limited to, the offer and sale of Common
Stock in one or more registered public offerings, the grant of awards under equity incentive plans, and issuance of shares of capital
stock in strategic transactions or to raise capital. The Board believes that additional authorized shares of capital stock will also enable
the Company to take timely advantage of market conditions and favorable acquisition opportunities that may become available to the Company.
Subject to reserve requirements under outstanding derivative securities, the authorized but unissued shares of Common Stock will be issued
at the direction of the Board, without shareholder approval unless required by applicable law or Nasdaq Rules.
Compensation Programs
We
have historically compensated our employees with RSUs and/or stock options in addition to salaries and other forms of cash compensation.
Our
non-employee directors receive compensation for their service as directors and members of committees of the Board, which has historically
been granted at the end of each calendar year and consisted of cash and/or stock awards. Our non-employee directors can elect to receive
restricted stock instead of all or a portion of their cash compensation for service as directors. Compensation for service on committees
of the Board is paid in shares of Common Stock.
If
approved by the shareholders, the Proposed Amendment will enable the Company to continue to compensate its directors in equity awards
under its compensation programs.
Rights of Additional Authorized Shares
Any newly authorized shares of Common
Stock will have the same rights as the shares of Common Stock now authorized and outstanding. The Proposed Amendment will not affect the
rights of current holders of Common Stock, none of whom have preemptive or similar rights to acquire the newly authorized shares.
Potential Adverse Effects of the Proposed Amendment
The Board has no current plans to
issue any additional shares of Common Stock following the effectiveness of the Proposed Amendment. Adoption of the Proposed Amendment
alone will not have any immediate dilutive effect on the proportionate voting power or other rights of the Company’s existing shareholders.
However, any issuance of Common Stock at the direction of the Board or otherwise in the future, generally without obtaining shareholder
approval (unless specifically required by applicable law or Nasdaq Rules) may, among other things, result in dilution to our shareholders
at the time such additional shares are issued.
Additionally, an increase in the
number of authorized shares of Common Stock may make it more difficult to, or discourage an attempt to, obtain control of the Company
by means of a takeover bid that the Board determines is not in the best interest of the Company and its shareholders. However, the Board
does not deem the proposed increase in the number of authorized shares of Common Stock pursuant to the Proposed Amendment as an anti-takeover
measure and is not aware of any attempt or plan by a third party to obtain control of the Company.
No Appraisal Rights
Shareholders have no rights under
the Delaware General Corporation Law or under our Certificate of Incorporation to exercise dissenters’ rights of appraisal with
respect to the approval of the Proposed Amendment.
THE BOARD OF DIRECTORS RECOMMENDS
THAT THE SHAREHOLDERS VOTE “FOR” THIS PROPOSAL 1.
PROPOSAL 2. THE ADJOURNMENT
PROPOSAL
The Company is asking shareholders
to approve, if necessary, adjournment of the Special Meeting to solicit additional proxies in favor of the Authorized Share Increase Proposal.
Any adjournment of the Special Meeting for the purpose of soliciting additional proxies will allow shareholders who have already sent
in their proxies to revoke them at any time prior to the time that the proxies are used.
Vote
Required
The affirmative vote of a majority
of the votes cast for or against this Proposal 2 is required to approve the Adjournment Proposal. Abstentions and will not be considered
as votes cast under the Company’s Bylaws, and accordingly will have no effect on the outcome of this Proposal 2.
THE BOARD OF DIRECTORS RECOMMENDS
THAT THE SHAREHOLDERS VOTE “FOR” THIS PROPOSAL 2.
Security
Ownership of Certain Beneficial Owners and Management
The following table sets forth the
number of shares of the Company’s Common Stock beneficially owned as of the Record Date by (i) those persons known by the Company
to be owners of more than 5% of its Common Stock, (ii) each director, (iii) the Named Executive Officers (as defined by Rule 402(m) of
Regulation S-K, and (iv) the Company’s executive officers and directors as a group. Unless otherwise specified in the notes to this
table, the address for each person is: c/o Aspen Group, Inc., 276 Fifth Avenue, Suite 505, New York, New York 10001, Attention: Corporate
Secretary.
Title of Class |
|
Beneficial Owner |
|
Amount of Beneficial Ownership (1) |
|
|
Percent Beneficially Owned (1) |
|
Named Executive Officers: |
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
Michael Mathews (2) |
|
|
901,281 |
|
|
|
3.6 |
% |
Common Stock |
|
Dr. Cheri St. Arnauld (3) |
|
|
243,698 |
|
|
|
1.0 |
% |
Common Stock |
|
Matthew LaVay (4) |
|
|
— |
|
|
|
— |
|
Common Stock |
|
Gerard Wendolowski (5) |
|
|
298,691 |
|
|
|
1.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
Robert Alessi(6) |
|
|
30,710 |
|
|
|
* |
|
Directors: |
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
Andrew Kaplan (7) |
|
|
179,376 |
|
|
|
* |
|
Common Stock |
|
Douglas Kass (8) |
|
|
142,894 |
|
|
|
* |
|
Common Stock |
|
Michael Koehneman (9) |
|
|
26,160 |
|
|
|
* |
|
Common Stock |
|
Dr. Joan Prince (10) |
|
|
9,060 |
|
|
|
* |
|
Common Stock |
|
Sanford Rich (11) |
|
|
149,538 |
|
|
|
* |
|
Common Stock |
|
All directors and executive officers as a group (10 persons) (12) |
|
|
1,996,408 |
|
|
|
7.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
5% Stockholders: |
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
Leon G. Cooperman (13) |
|
|
2,495,026 |
|
|
|
9.9 |
% |
Common Stock |
|
Calm Waters Partnership (14) |
|
|
2,436,307 |
|
|
|
9.6 |
% |
———————
* Less than 1%.
(1) |
Beneficial Ownership Note. Applicable percentages are based on 25,202,278 shares of Common Stock outstanding as of the Record Date, excluding securities held by or for the account of the Company. Beneficial ownership is determined under the rules of the SEC and generally includes voting or investment power with respect to securities. A person is deemed to be the beneficial owner of securities that can be acquired by such person within 60 days whether upon the exercise of options, warrants or conversion of notes. Unless otherwise indicated in the footnotes to this table, the Company believes that each of the stockholders named in the table has sole voting and investment power with respect to the shares of Common Stock indicated as beneficially owned by them. This table does not include any unvested stock options except for those vesting within 60 days. |
(2) |
Mathews. Mr. Mathews is our Chairman and Chief Executive Officer. Includes (i) 2,917 shares held jointly with his spouse, and (ii) 8,334 shares held by a trust of which Mr. Mathews is the trustee. Does not include (i) 65,000 shares underlying restricted stock units, or RSUs, that are subject to stock price based vesting or otherwise vesting in 2024, (ii) 15,157 shares underlying RSUs vesting on July 8, 2023, or (iii) 125,000 shares underlying RSUs that vest following the Company’s filing of a quarterly or annual report on Forms 10-Q or 10-K as applicable, which report directly or indirectly reflects that the Company delivered net income on a GAAP basis for the fiscal quarter covered by such report. |
(3) |
St. Arnauld. Dr. St. Arnauld is our Chief Academic Officer and President of Aspen University. Includes 180,000 shares underlying vested stock options. Does not include (i) 48,750 shares underlying RSUs that are subject to stock price based vesting or otherwise vesting in 2024, (ii) 13,991 shares underlying RSUs vesting on July 8, 2023, or (iii) 80,000 RSUs which vest in three approximately equal annual installments beginning on August 12, 2022. |
(4) |
LaVay. Mr. LaVay is our Chief Financial Officer. Does not include 125,000 RSUs which vest in three approximately equal annual installments beginning on August 16, 2022. |
(5) |
Wendolowski. Mr. Wendolowski is our Chief Operating Officer. Includes 180,000 shares underlying vested stock options. Does not include (i) 48,750 shares underlying RSUs that are subject to stock price based vesting or otherwise vesting in 2024, (ii) 13,991 shares underlying RSUs vesting on July 8, 2023, or (iii) 80,000 RSUs which vest in three approximately equal annual installments beginning on August 12, 2022. |
(6) |
Alessi. Mr. Alessi is our Chief Accounting Officer. Includes 8,333 vested stock options. |
(7) |
Kaplan. Mr. Kaplan is a director. Includes 50,000 shares underlying vested stock options. |
(8) |
Kass. Mr. Kass is a director. Includes 123,000 shares held by Seabreeze Capital Partners LP, of which Mr. Kass is the general partner. |
(9) |
Koehneman. Mr. Koehneman is a director. Includes 2,000 shares held by Michael Koehneman Roth IRA. |
(10) |
Prince. Dr. Prince is a director. |
(11) |
Rich. Mr. Rich is a director. Includes (i) 2,188 shares held in the name of Mr. Rich’s IRA and (ii) 71,000 shares underlying vested stock options. |
(12) |
Directors and Executive Officers as a group. This amount includes ownership by all directors and all current executive officers including those who are not Named Executive Officers under the SEC’s disclosure rules. |
(13) |
Leon G. Cooperman. Based on a Schedule 13G filed on February 14, 2022 which reported beneficial ownership as of December 31, 2021. Mr. Cooperman is the trustee of The Leon and Toby Cooperman Family Foundation. Address is St. Andrew’s Country Club, 7118 Melrose Castle Lane, Boca Raton, FL 33496. Also includes a portion of the 100,000 shares of Common Stock underlying warrants approved by the Board on April 16, 2022, which is subject to a 9.9% beneficial ownership limitation. Does not include shares of Common Stock underlying a $5,000,000 Convertible Promissory Note convertible into 5,000,000 shares Common Stock which is subject to a 9.9% beneficial ownership limitation. |
(14) |
Calm Waters Partnership. Based on a Schedule 13D filed on March 21, 2022. Mr. Richard S. Strong is the Managing Partner of Calm Waters Partnership. Address is 115 South 84th Street, Suite 200, Milwaukee, WI 53214. Includes 100,000 shares of Common Stock underlying warrants approved by the Board on April 16, 2022 and shares of Common Stock underlying a $5,000,000 Convertible Promissory Note convertible into 5,000,000 shares Common Stock which is subject to a 9.9% beneficial ownership limitation. |
OTHER MATTERS
The Company has no knowledge of
any other matters that may come before the Special Meeting and does not intend to present any other matters.
If you do not plan to attend the
Special Meeting, in order that your shares may be represented and in order to assure the required quorum, please sign, date and return
your proxy promptly. In the event you are able to attend the Special Meeting, at your request, the Company will cancel your previously
submitted proxy.
Annex A
CERTIFICATE OF AMENDMENT TO THE
CERTIFICATE OF INCORPORATION
OF
ASPEN GROUP, INC.
Pursuant to the provisions of Section
242 of the General Corporation Law of the State of Delaware, Aspen Group, Inc., a Delaware Corporation (the “Corporation”),
in order to amend its Certificate of Incorporation, as amended, hereby certifies as follows:
FIRST: The name of the Corporation is Aspen
Group, Inc.
SECOND: That the Board
of Directors of the Corporation adopted resolutions setting forth a proposed amendment to the Corporation’s Certificate of Incorporation,
as amended, declaring said amendment to be advisable and in the best interests of the Corporation and its shareholders, and calling a
meeting of the shareholders of the Corporation for consideration thereof. The resolution setting forth the proposed amendment is as follows:
RESOLVED,
that the Board has determined it to be advisable and in the best interests of the Company and its shareholders to amend Section 4
of the Certificate of Incorporation, as amended, of the Company (the “Certificate of Incorporation”) by replacing the first
sentence of said Section with the following sentence:
The
total number of shares of stock of all classes and series the Company shall have authority to issue is 61,000,000 shares consisting of
(i) 60,000,000 shares of Common Stock, par value of $0.001 per share and (ii) 1,000,000
shares of Preferred Stock, par value $0.001 with such rights, preferences and limitations as may be set from time to time by resolution
of the board of directors and the filing of a certificate of designation as required by the Delaware General Corporation Law.
THIRD: That thereafter, pursuant
to resolution of the Board of Directors, a special meeting of the shareholders of the Corporation was duly called and held upon notice
in accordance with Section 222 of the General Corporation Law of the State of Delaware at which meeting the necessary number of shares
as required by statute were voted in favor of the amendment.
FOURTH: That said amendment was
duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.
IN WITNESS WHEREOF, the Corporation
has caused this certificate to be signed this [___] day of [_______], 2022.
|
ASPEN GROUP, INC. |
|
|
|
|
By: |
|
|
|
Michael Mathews
Chief Executive Officer |
PRELIMINARY PROXY CARD
ASPEN GROUP, INC.
276 FIFTH AVENUE, SUITE 505
NEW YORK, NY 10001-4509 |
VOTE BY INTERNET - www.proxyvote.com
Use the Internet to transmit your
voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on July 5, 2022. Have your proxy card
in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting
instruction form. |
|
ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
If you would like to reduce the costs
incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports
electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the
Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years. |
|
|
|
VOTE BY PHONE – 1-800-690-6903
Use any touch-tone telephone to
transmit your voting instructions up until 11:59 p.m. Eastern Time on July 5, 2022. Have your proxy card in hand when you call and
then follow the instructions. |
|
|
|
VOTE BY MAIL
Mark, sign and date your proxy card
and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood,
NY 11717. |
|
|
|
VOTE IN PERSON
You may vote the shares in person by
attending the Special Meeting. |
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: |
KEEP THIS PORTION FOR YOUR RECORDS |
— — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — |
|
|
DETACH AND RETURN THIS PORTION ONLY |
|
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. |
|
ASPEN GROUP, INC. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommends you vote FOR proposals 1 and 2. |
|
For |
Against |
Abstain |
|
|
|
|
|
|
|
|
1. |
Approve an increase in the number of authorized shares of Common Stock from 40,000,000 shares to 60,000,000 shares (the “Authorized Share Increase”), and approve a corresponding amendment to the Company’s certificate of incorporation, as amended, to effect the Authorized Share Increase. |
|
¨ |
¨ |
¨ |
|
|
|
|
|
|
|
|
2. |
Approve the adjournment of the Special Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve the Authorized Share Increase. |
|
¨ |
¨ |
¨ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For address changes and/or comments, please check this box and write them on the back where indicated. ¨ |
|
|
|
|
|
|
|
|
|
|
|
|
Please indicate if you plan to attend this meeting |
¨ |
¨ |
|
|
|
|
|
|
|
|
|
Yes |
No |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor,
administrator, or other fiduciary, please give full title as such. Joint owners should each sign
personally. All holders must sign. If a corporation or partnership, please sign in full corporate
or partnership name by authorized officer. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature [PLEASE SIGN WITHIN BOX] |
Date |
|
Signature (Joint Owners) |
Date |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Important Notice
Regarding the Availability of Proxy
Materials for the Special Meeting:
The Notice and
Proxy Statement are available at www.proxyvote.com.
|
|
— — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — |
|
|
|
|
|
|
|
ASPEN GROUP, INC. |
Special Meeting of Shareholders |
July
6, 2022 |
This proxy is solicited on behalf of the Board of Directors |
|
The shareholder(s) hereby appoint(s) Michael Mathews and
Matthew LaVay, or either of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them to represent
and to vote, as designated on the reverse side of this ballot, all of the shares of Common Stock of ASPEN GROUP, INC. that the shareholder(s)
is/are entitled to vote at the Special Meeting of Shareholders to be held at 9:30 a.m., local time on July 6, 2022, at the Company’s
offices located at 4615 E. Elwood Street, Phoenix, Arizona 85040, and any adjournment or postponement thereof. |
|
This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors’ recommendations. |
|
|
|
|
|
|
|
|
Address Changes/Comments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
(If you noted any Address Changes/Comments above, please mark corresponding box on the reverse side.) |
|
Continued and to be signed on reverse side |
|
|
|
|
|
|
Aspen (NASDAQ:ASPU)
Historical Stock Chart
From Dec 2024 to Jan 2025
Aspen (NASDAQ:ASPU)
Historical Stock Chart
From Jan 2024 to Jan 2025